跳至主要内容
临床试验/NCT01326494
NCT01326494已完成4 期

Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia

University of British Columbia1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2011年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
92
试验地点
1
主要终点
Reduction of representation to Health Services for Exacerbation of URTI induced asthma

研究概览

简要总结

The purpose of this study is to investigate the benefits of giving filled prescription of a medication to be used upon early onset of symptoms of URTI induced asthma. The hope is to reduce the need to present to Health Care centres for treatment.

详细描述

In Canada, asthma affects more the 12% of children. Exacerbation are a common feature of asthma. In children, upper respiratory tract infection (URTI's) are responsible for over 80% of asthma exacerbation.

Experts in asthma care acknowledge this critical problem and have developed guidelines to reduce asthma exacerbation.

The criteria for participation in this study to have 2 or more presentations to a Health Service centre in the past 12 months for URTI induced asthma. These patients will be followed and interviewed monthly over a 12 month period to investigate whether the use of Oral cortico-steroids upon early onset of URTI induced asthma prevents the need for presentation to hospital

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
12 Months 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • 2 or more presentations to Emergency department in a 12 month period

排除标准

  • less then 2 presentations to Emergency department in a 12 month period

研究组 & 干预措施

Arm 1 Oral Cortico Steroid

Active Comparator

A filled prescription will be given to be used upon early onset of symptoms.

干预措施: Arm 1 Oral Cortico Steroids (Drug)

结局指标

主要结局

Reduction of representation to Health Services for Exacerbation of URTI induced asthma

时间窗: One year

To review the effect of medication given at early onset of symptoms have on reducing the presentation to Health Services and Emergency Departments.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bruce Carleton

Principle Investigator

University of British Columbia

研究点 (1)

Loading locations...

相似试验